Despite Some Concerns, Quintiles Says Asia Will Become Strategic Imperative For Pharmaceutical Companies - Singapore Conference
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - "Pharmaceutical outsourcing to Asia is shifting from tactical to a strategic imperative that builds upon the region's experience and expertise," experts at Quintiles said in a report released March 17
You may also be interested in...
Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal
MUMBAI - Quintiles Transnational Corp.'s India CEO Ferzaan Engineer will step down after serving the multinational contract research organization since its inception in India more than 13 years ago
Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal
MUMBAI - Quintiles Transnational Corp.'s India CEO Ferzaan Engineer will step down after serving the multinational contract research organization since its inception in India more than 13 years ago
Asia Pacific Key To Speeding Up Global Drug Development, Says Quintiles VP Anand Tharmaratnam (Part 1 Of 2)
Globalization of clinical trials is perhaps Asia's main role in advancing the pharmaceutical industry, says Quintiles Asia Pacific Head of Clinical Development Anand Tharmaratnam, who discussed innovation in Asia Pacific with PharmAsia News' Australia Bureau. Key to that innovation is a lack of legacy informationin that the past is not holding the industry back, and virtual opportunitiesand private/public cooperative partnerships offer ripe benefits.